HMPV reaches India: Is there a vaccine to combat the virus spreading across the world?Union Health Ministry confirmed two cases of Human Metapneumovirus in India, with infants diagnosed in Bengaluru. Both are recovering. The ...
06 Jan, 2025, 05.29 PM IST
What is HMPV? Its symptoms, transmission and prevention explainedHuman Metapneumovirus (HMPV) is a respiratory virus that has recently gained attention due to an outbreak in China. It causes respiratory i...
06 Jan, 2025, 05.27 PM IST
Viral video showing HMPV chaos at China hospital raises alarm. Is human metapneumovirus a new virus?HMPV surge in China: China is dealing with an outbreak of respiratory illness- Human Metapnuemovirus (HMPV) which has raised concerns all o...
06 Jan, 2025, 05.04 PM IST
What's HMPV and its symptoms: How to know if you are infected, how to diagnose itHMOV Symptoms: An outbreak of Human Metapneumovirus (HMPV) in China has raised global concerns. India is also monitoring the virus. Symptom...
06 Jan, 2025, 12.50 PM IST
HMPV virus cases rising across the world: Symptoms, treatment, diagnosis and everything else you should knowHMPV Virus Symptoms: A Human Metapneumovirus (HMPV) outbreak in China has raised global concerns, with countries monitoring the situation c...
06 Jan, 2025, 11.46 AM IST
Health Min monitoring respiratory, seasonal influenza cases amid Covid-like HMPV outbreak in China: SourcesThe National Centre for Disease Control (NCDC) closely monitors respiratory and seasonal influenza cases in India and is on alert following...
04 Jan, 2025, 11.26 AM IST
Sanofi gets drug regulator nod to market RSV therapy in IndiaFrench drugmaker Sanofi announced on Thursday that it has received approval from India's Central Drugs Standard Control Organization (CDSCO...
01 Aug, 2024, 07.07 PM IST
Pfizer Q1 Results: Co lifts profit view on cost cuts, smaller drop in PaxlovidPfizer lifted its annual earnings forecast on Wednesday and reported a first-quarter profit above Wall Street estimates, boosted by cost cu...
01 May, 2024, 07.54 PM IST
AstraZeneca bets on licencing deals, public-private partnerships for India growthBritish-Swedish drugmaker AstraZeneca is set to launch 15 new products in India from 2023 to 2025, focusing on oncology, cardiovascular, re...
09 Mar, 2024, 12.53 AM IST
AstraZeneca targets 2024 growth but mixed views hit sharesIn almost a decade since AstraZeneca fended off a takeover by U.S. rival Pfizer, CEO Pascal Soriot has rebuilt the Anglo-Swedish drugmaker'...
09 Feb, 2024, 12.15 AM IST
GSK boosts respiratory portfolio with $1.4 bn Aiolos Bio dealGSK will pay $1 billion upfront and up to $400 million in certain success-based regulatory milestone payments. It will also make milestone ...
09 Jan, 2024, 05.43 PM IST
AstraZeneca gets CDSCO approval for preventive therapy for respiratory syncytial virusThis innovative therapy is indicated for prevention of serious lower respiratory tract disease requiring hospitalisation caused by Respirat...
30 Sep, 2023, 09.38 PM IST
AstraZeneca may not stay in vaccines, but CEO has no COVID regretsSoriot was tasked with turning around a troubled AstraZeneca - hit by a string of key patent losses and a spate of clinical trial failures ...
23 Aug, 2022, 09.43 PM IST
Johnson & Johnson expects nod for Covid vaccine by early 2021: Paul Stoffels, chief scientific officer, J&JScientists and drug companies across the world are accelerating various treatments and vaccine options to tackle Covid-19, which has claime...
15 Jun, 2020, 10.50 AM IST